“Prognostic value of neutrophil-to-lymphocyte ratio in mCRPC patients treated with abiraterone, enzalutamide and docetaxel: a retrospective single-center study”, Arch Ital Urol Androl, Aug. 2026, doi: 10.4081/aiua.2026.15630.